<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04149158</url>
  </required_header>
  <id_info>
    <org_study_id>SNTCT2015</org_study_id>
    <nct_id>NCT04149158</nct_id>
  </id_info>
  <brief_title>Evaluation of Sinetrol速 Xpur in Fat Mass Reduction on Overweight and Obese Subjects</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fytexia</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fytexia</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims to evaluate effects of a 16-week supplementation with a polyphenol rich
      extract, Sinetrol速 Xpur, on fat mass accumulation and body weight management
      improvement.Subjects were overweight or obese and received polyphenol supplement or placebo.
      A 4-week follow-up as performed to evaluate its effect after supplementation stop.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 2015</start_date>
  <completion_date type="Actual">September 2017</completion_date>
  <primary_completion_date type="Actual">September 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in total body fat percentage loss versus bodyweight</measure>
    <time_frame>week1; week16; week20</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">77</enrollment>
  <condition>Change in Total Body Fat Mass Percentage Loss Versus Body Weight</condition>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Verum</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Sinetrol速 Xpur</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Sinetrol速 Xpur</intervention_name>
    <arm_group_label>Verum</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  overweight or obese (25 kg.m-2&lt;BMI&lt;42.5kg.m-2)

          -  healthy

        Exclusion Criteria:

          -  metabolic or chronical disease with treatments (i.e.: diabetes, dyslipidemia,
             thyroiditis, inflammatory disease, immunological disease, infectious disease, asthma,
             anxiety and depression)

          -  food allergy to the ingredients of the product (grapefruit, orange, caffeine, guarana)

          -  involved in the prior 6 months in a chronic treatment program, eating disorders
             history, subjected to weight reduction by surgery

          -  start or quit smoking, high alcohol consumption

          -  pregnant, breastfeeding, wanting to have a baby,

          -  menopausal women
      </textblock>
    </criteria>
    <gender>All</gender>
    <gender_based>Yes</gender_based>
    <gender_description>stratification of sex (40%minimum and 60% maximum of each sex)</gender_description>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pedro Alcaraz Ramon</last_name>
    <role>Principal Investigator</role>
    <affiliation>UCAM</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>UCAM</name>
      <address>
        <city>Murcia</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>October 2019</verification_date>
  <study_first_submitted>October 31, 2019</study_first_submitted>
  <study_first_submitted_qc>October 31, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">November 4, 2019</study_first_posted>
  <last_update_submitted>October 31, 2019</last_update_submitted>
  <last_update_submitted_qc>October 31, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">November 4, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Body Weight</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

